Chemistry:Oxitropium bromide

From HandWiki
Short description: Chemical compound

Oxitropium bromide
Clinical data
Trade namesOxivent, Tersigan, Tersigat, Ventilat
Other namesN-Ethylscopolammonium bromide; Ba 253; Ba 253BR-L; Ba 253Br; Hyoscine ethobromide; N-Ethylnorscopolamine methyl bromide; Scopolamine ethobromide
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC19H26BrNO4
Molar mass412.324 g·mol−1
3D model (JSmol)

Oxitropium bromide (trade names Oxivent, Tersigan) is an anticholinergic used as a bronchodilator for the treatment of asthma and chronic obstructive pulmonary disease.[1]

It was patented in 1966 and approved for medical use in 1983.[2]

It is a thermosalient material.[3]

Synthesis

upright=2

Two successive alkylation reactions convert a natural product, norscopolamine (1), into oxitropium bromide. [4] The first, with bromoethane, gives an N-ethyl intermediate (2), which is treated with bromomethane.[5][6][7]

References

  1. "Use of inhaled anticholinergic agents in obstructive airway disease". Respiratory Care 52 (7): 833–851. July 2007. PMID 17594728. 
  2. (in en) Analogue-based Drug Discovery. John Wiley & Sons. 2006. p. 447. ISBN 9783527607495. https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA447. 
  3. "The thermosalient phenomenon. "Jumping crystals" and crystal chemistry of the anticholinergic agent oxitropium bromide". Journal of the American Chemical Society 132 (40): 14191–14202. October 2010. doi:10.1021/ja105508b. PMID 20860383. Bibcode2010JAChS.13214191S. 
  4. "(S)-scopolamine and (S)-norscopolamine from Atropanthe sinensis". Planta Medica 61 (3): 292–293. June 1995. doi:10.1055/s-2006-958082. PMID 7617778. Bibcode1995PlMed..61R.292R. 
  5. Banholzer R, Schulz W, Walther G, Wick H, Zeile K, "N-substitution products of norscopolamine and quaternary salts thereof", US patent 3472861, issued 14 October 1969
  6. Banholzer R, Schulz W, Zeile K, "Process for the preparation of (-)-norscopolamine", US patent 3538102, issued 3 November 1970, assigned to CH Boehringer Sohn AGand Co KG, Boehringer Ingelheim GmbH
  7. "Oxitropium bromide". Thieme. https://pharmaceutical-substances.thieme.com/ps/search-results?docUri=KD-15-0045.